🫁 Pulmonary Nodule Smart Manager · Follow-up & Surgical Decision
This tool turns nodule type, size, scenario, risk, and dynamics into classification, malignancy stratification, follow-up, diagnostic approach, surgical window, and procedure recommendation in one pass.
Pulmonary Nodule Smart Manager · Follow-up & Surgical Decision
Detection scenario
Nodule type
Total nodule diameter (mean) (mm)
Solid-component diameter (required for part-solid) (mm)
Lung-cancer risk
Compared with prior CT
Number
Location (affects procedure)
When to use
Use to classify by Lung-RADS (screening) or Fleischner (incidental), refine follow-up with the Chinese 2024 consensus, and gauge the surgical window and procedure.
How it works
Screening → Lung-RADS category by type/size/solid component. Incidental → Fleischner by type and size. Surgical window triggered by Lung-RADS 4B, solid > 8 mm, part-solid solid component ≥ 6 mm, or persistent enlarging GGN ≥ 10 mm.
Key points
- Sublobar resection requires preoperatively negative mediastinal staging, and intraoperative N1/N2 mandates conversion to lobectomy. (original synthesis · not guideline verbatim)
- Pure GGN is prone to PET false-negatives and a long doubling time does not exclude indolent adenocarcinoma.
- Solid-component size and growth are the core invasiveness markers driving escalation.
References
- MacMahon H, et al. Guidelines for Management of Incidental Pulmonary Nodules: From the Fleischner Society 2017. Radiology 2017.
- Saji H, et al. Segmentectomy versus lobectomy in small-sized peripheral NSCLC (JCOG0802/WJOG4607L). Lancet 2022.
Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.